SEC CIK 1190128
TOBIN JAMES R
Reported ownership across 3 companies, sourced from SEC Form 4 filings and updated daily.
Current Positions
| Company | Shares Owned | As Of |
|---|---|---|
| BSXview stock → | 550,000 | 2008-10-09 |
| CRISview stock → | 186,751 | 2013-05-06 |
| GMEDview stock → | 0 | 2026-09-15 |
Position History — GMED
Reported shares owned immediately after each Form 4 transaction, over time.
Recent Filings — GMED
| Date | Activity | Shares | Price | Owned After |
|---|---|---|---|---|
| 2026-09-15 | Option exercise (derivative) | 15,000 | $0.00 | 0 |
| 2026-09-15 | Open-market sale | 30,000 | $74.58 | 0 |
| 2026-09-15 | Option exercise | 15,000 | $63.68 | 30,000 |
| 2026-09-15 | Option exercise | 15,000 | $53.75 | 15,000 |
| 2026-01-21 | Grant / award (derivative) | 15,000 | $0.00 | 15,000 |
| 2025-01-23 | Grant / award (derivative) | 15,000 | $0.00 | 15,000 |
| 2024-01-26 | Grant / award (derivative) | 15,000 | $0.00 | 15,000 |
| 2023-01-26 | Grant / award (derivative) | 15,000 | $0.00 | 15,000 |
| 2022-03-15 | Option exercise (derivative) | 5,308 | $0.00 | 5,208 |
| 2022-03-15 | Option exercise (derivative) | 3,542 | $0.00 | 21,458 |
| 2022-03-15 | Open-market sale | 8,850 | $65.47 | 0 |
| 2022-03-15 | Option exercise | 3,542 | $53.27 | 8,850 |
| 2022-03-15 | Option exercise | 5,308 | $43.58 | 5,308 |
| 2022-03-10 | Option exercise (derivative) | 10,000 | $0.00 | 10,516 |
| 2022-03-10 | Option exercise | 10,000 | $43.58 | 10,000 |
| 2022-03-10 | Open-market sale | 10,000 | $70.04 | 0 |
| 2022-03-08 | Option exercise (derivative) | 4,484 | $0.00 | 20,516 |
| 2022-03-08 | Option exercise | 4,484 | $43.58 | 4,484 |
| 2022-03-08 | Open-market sale | 4,484 | $72.00 | 0 |
| 2022-01-27 | Grant / award (derivative) | 15,000 | $0.00 | 15,000 |
| 2021-05-10 | Option exercise (derivative) | 25,000 | $0.00 | 0 |
| 2021-05-10 | Option exercise | 25,000 | $43.77 | 25,000 |
| 2021-05-10 | Open-market sale | 25,000 | $71.96 | 0 |
| 2021-01-14 | Grant / award (derivative) | 15,000 | $0.00 | 15,000 |
| 2020-09-02 | Option exercise (derivative) | 5,600 | $0.00 | 0 |
| 2020-09-02 | Open-market sale | 5,600 | $56.85 | 0 |
| 2020-09-02 | Option exercise | 5,600 | $26.27 | 5,600 |
| 2020-08-25 | Option exercise (derivative) | 17,400 | $0.00 | 5,600 |
| 2020-08-25 | Option exercise | 17,400 | $26.27 | 17,400 |
| 2020-08-25 | Open-market sale | 17,400 | $54.40 | 0 |
| 2020-01-22 | Grant / award (derivative) | 25,000 | $0.00 | 25,000 |
| 2019-02-28 | Option exercise (derivative) | 20,000 | $0.00 | 0 |
| 2019-02-28 | Option exercise (derivative) | 2,000 | $0.00 | 23,000 |
| 2019-02-28 | Option exercise | 2,000 | $26.27 | 28,100 |
| 2019-02-28 | Option exercise | 20,000 | $25.52 | 26,100 |
| 2019-02-28 | Open-market sale | 18,800 | $48.10 | 9,300 |
| 2019-02-28 | Open-market sale | 9,300 | $47.04 | 0 |
| 2019-02-28 | Option exercise | 6,100 | $24.75 | 6,100 |
| 2019-02-26 | Option exercise (derivative) | 8,900 | $0.00 | 6,100 |
| 2019-02-26 | Option exercise | 8,900 | $24.75 | 8,900 |
| 2019-02-26 | Open-market sale | 400 | $47.91 | 0 |
| 2019-02-26 | Open-market sale | 8,500 | $47.06 | 400 |
| 2019-01-22 | Grant / award (derivative) | 25,000 | $0.00 | 25,000 |
| 2018-01-22 | Grant / award (derivative) | 25,000 | $0.00 | 25,000 |
| 2017-01-30 | Grant / award (derivative) | 25,000 | $0.00 | 25,000 |
| 2016-01-25 | Grant / award (derivative) | 20,000 | $0.00 | 20,000 |
| 2015-08-28 | — | — | — | 0 |
| 2015-08-28 | Grant / award (derivative) | 15,000 | $0.00 | 15,000 |
Source: SEC EDGAR Form 4 filings. For informational purposes only — not investment advice.